StockGlow

Halozyme Therapeutics, Inc. (RV7.F)

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally.

72.16-0.00%Healthcare
Compare RV7.F with
StockGlow Score
96
Bullish
BearishBullish
1 year ago+38.2%

The outlook

Halozyme Therapeutics, Inc. currently reads as bullish based on above its 50- & 200-day averages, 97% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range97% of the way from its 52-week low to high
Market cap
$8.56B
52-wk high
72.76
52-wk low
50.70
50-day avg
64.02
200-day avg
59.93
Trailing P/E
28.9

Similar stocks

2L9.FVisionWave Holdings, Inc.$1.63-3.66%UP0.FUltragenyx Pharmaceutical Inc.$22.52+4.89%HDP1.FArrowhead Pharmaceuticals, Inc.$75.64+0.05%J7Z.FJazz Pharmaceuticals plc$224.10+0.36%ISI.FIonis Pharmaceuticals, Inc.$46.26-0.64%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy